Abstract:The omega 3 polyunsaturated fatty acids have had a major impact on thinking in medicine in the last twenty-five years. The parent fatty acid in the omega 3 fatty acid family is alpha-linolenic acid (ALA) which is an essential fatty acid found in high concentrations in certain plant oils, such as flaxseed oil, walnut oil and canola oil. Several longer chain or derived omega 3 fatty acids are formed in the body from ALA, including eicosapentaenoic acid, EPA, decosapentaenoic acid and docosahexaenoic acid, DHA. Dietary sources of these longer-chain fatty acids are fish, fish oils and from other marine organisms. DHA is specifically localised in the retina and the brain in humans and other mammals where it has a primary role via effects on membrane order (fluidity), the activity of membrane-bound enzymes, ion channels and signal transduction. For many years, ALA has been considered to be important only as a precursor of these longer chain compounds, however it is now recognaised that ALA is metabolished by other pathways which may be quantiatively more important than the formation of DHA. For example, ALA is extensively β-oxidised in mammals including humans, especially on diets rich in polyunsaturated fatty acids. ALA appears to play an important role in the nervous system (carbon recycling) for the synthesis of saturated and monounsaturated fatty acids and cholesterol, with estimates of the proportion of ALA being matabolised via this pathway being several fold greater than that to DHA. Furthermore, recent studies have indicated that ALA is deposited in the skin of small mammals and may also play a role in fur. Since ALA is extensively metabolised via these pathways (β-oxidation, carbon recycling and deposition in skin/fur) and is subject to competitive inhibition from linoleic acid in metabolism via the delta-6 desaturase, it is not surprising tha dietary DHA is substantially more effctive than an equivalent dose of dietary ALA in maintaining neural DHA levels. Despite the limited efficiency of DHA formation from ALA, it is clear that certain tissues possess the capacity to synthesise DHA at rates greater than other tissues. The brain, retina and reproductive tissue may be able to synthesis sufficient DHA to meet the DHA demands of these tissues, although in infants at the peak of brain growth and DHA deposition, a dietary supply of DHA (as in milk) may be important to maintain the brain DHA level. In plants, ALA is a substrate for lipoxygenase enzymes leading to the poduction of bioactive hydroxy compounds. This information might provide a clue to other routes of ALA metabolism in mammals. It is concluded that it may no longer be appropriate to consider the function for ALA to be solely a precursor of EPA and DHA.

DHA: Can It Benefit Salmon Marketing?

DHA Modulates Immune Response and Mitochondrial Function of Atlantic Salmon Adipocytes after LPS Treatment

Optimum eicosapentaenoic acid + docosahexaenoic acid levels for farmed Atlantic salmon: closing the gap between science and commercial practice

How does high DHA fish oil affect health? A systematic review of evidence

Challenges in estimating omega-3 fatty acid content of seafood from US nutrient databases: A salmon case study

Effects of Varying Dietary Docosahexaenoic, Eicosapentaenoic, Linoleic, and α-Linolenic Acid Levels on Fatty Acid Composition of Phospholipids and Neutral Lipids in the Liver of Atlantic Salmon, Salmo salar

Preliminary Validation of a High Docosahexaenoic Acid (DHA) and -Linolenic Acid (ALA) Dietary Oil Blend: Tissue Fatty Acid Composition and Liver Proteome Response in Atlantic Salmon (Salmo salar) Smolts

A Piece of the Puzzle—Possible Mechanisms for Why Low Dietary EPA and DHA Cause Hepatic Lipid Accumulation in Atlantic Salmon (Salmo salar)

The Significance of Alpha-Linolenic Acid for Humans.

Influence of Dietary Long-Chain Polyunsaturated Fatty Acids and ω6 to ω3 Ratios on Head Kidney Lipid Composition and Expression of Fatty Acid and Eicosanoid Metabolism Genes in Atlantic Salmon (Salmo salar)

Diet and Life Stage-Associated Lipidome Remodeling in Atlantic Salmon

Long-term feeding of Atlantic salmon in seawater with low dietary long-chain n-3 fatty acids affects tissue status of the brain, retina and erythrocytes

EPA, DHA, and Lipoic Acid Differentially Modulate the n-3 Fatty Acid Biosynthetic Pathway in Atlantic Salmon Hepatocytes

Docosahexaenoic Acid-Enriched Diet Improves the Flesh Quality of Freshwater Fish ( Megalobrama Amblycephala): ): Evaluation Based on Nutritional Value, Texture and Flavor

DHA prevents altered 5-HT1A, 5-HT2A, CB1 and GABAA receptor binding densities in the brain of male rats fed a high-saturated-fat diet.

Docosahexaenoic Acid-Enriched Diet Improves the Flesh Quality of Freshwater Fish (megalobrama Amblycephala): Evaluation Based on Nutritional Value, Texture and Flavor

Inclusion of oil from transgenic Camelina sativa in feed effectively supplies EPA and DHA to Atlantic salmon (Salmo salar) grown to market size in seawater pens

Impact of Reduced Dietary Levels of Eicosapentaenoic Acid and Docosahexaenoic Acid on the Composition of Skin Membrane Lipids in Atlantic Salmon ( Salmo Salar L.).

The long-chain monounsaturated cetoleic acid improves the efficiency of the n-3 fatty acid metabolic pathway in Atlantic salmon and human HepG2 cells

Omega-3 Fatty Acids EPA and DHA: Health Benefits Throughout Life

Dietary sources, current intakes, and nutritional role of omega‐3 docosapentaenoic acid